Abbott invites you to this educational webinar:
Lab, ED & Cardiology perspective
03 November 2025
6:00-7:00 PM CET (12 PM EST)Agenda & Presenters
The Role of Point-of-Care Troponin Testing in Acute Cardiac Care
Presenter | Prof Rick Body Impact of rapid hs-cTn-based ESC-algorithms for the Patients & the Healthcare System
Presenter | Prof Christian Mueller IFCC Committee consensus on clinical applications of cardiac biomarkers
Presenter | Prof Paul CollinsonBridging the gap between Emergency Medicine, Cardiology and Lab
Discussion | All
By clicking Submit you agree that your personal information will be used in accordance with the Website Terms and Conditions and Privacy Policy: US Citizens | Non-US Citizens. Please do not include personally identifiable information such as name, email or ID linked to anyone’s identity in free form text fields. All information submitted will be accessible by our global teams based in various countries including the United States. You can opt out at any time by clicking on the unsubscribe link at the bottom of each communication.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.
Lorem ipsum dolor sit amet, consectetur adipisicing, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. Ut ad minim veniam.
Vestibulum ante ipsum primis in faucibus orci luctus etel ultrices posuere cubilia Curae.
Sed ut perspiciatis unde omnis iste natus error sit voluptatem!
Nemo enim ipsam voluptatem quia voluptas sit odit aut fugit!
Ut enim ad minima veniam, quis nostrum exercitationem ullam!
Rick Body works as an Honorary Consultant & Group Director of Research & Innovation at Manchester University NHS Foundation Trust, which includes 10 hospitals and two major trauma centres. He is Deputy National Specialty Lead for Trauma & Emergency Care at the National Institute for Health Research (NIHR) Clinical Research Network, Deputy Editor at the Emergency Medicine Journal, Industry Lead for the Manchester NIHR Biomedical Research Centre and a member of the International Federation for Clinical Chemistry Committee for Clinical Applications of Cardiac Biomarkers. His main area of research interest is in diagnostics, particularly applied to acute coronary syndromes. He has developed and validated several early rule-out pathways for acute myocardial infarction that are in widespread practice.
Prof. Mueller earned a medical degree from the University of Munich, Germany, with postgraduate training in internal medicine, intensive care medicine, and cardiology in Germany and Switzerland. With the support of the Swiss National Science Foundation and the Swiss Heart Foundation, he established his own research group at Basel University Hospital in 2000. His research aims to improve early diagnosis and management of cardiovascular disorders, particularly heart failure and myocardial infarction. He was awarded a SNF professorship at Basel University in 2004, and promoted to full professor in 2011. Dr. Mueller is co-founder and director of the Cardiovascular Research Institute Basel (CRIB), member of several ESC experts committees, president of the GREAT network, and associate editor for the European Heart Journal. he has authored more than 1000 peer-reviewed publications. He particularly enjoys to supporting & mentoring young physician scientists.
Paul Collinson is a distinguished figure in the realm of pathology and biomarker expertise. With an illustrious career spanning decades, Prof. Collinson has emerged as a leading authority in his field of biomarkers, renowned for his groundbreaking research and invaluable contributions to diagnostics in health care. Dr Collinson was consultant chemical pathologist at St George's University Hospitals NHS Foundation Trust and is now Professor at St George’s University of London and actively engaged in research in the biomarker field. His main clinical interests are in hyperlipidaemia, the primary and secondary prevention of cardiac disease and complex lipid disorders. He was expert advisor to the National Institute for Health and Clinical Excellence (NICE) on cardiac biomarkers, and is responsible for developing and introducing troponin and B-type natriuretic peptide measurements to the UK. As a respected academic, Prof. Collinson has shared his knowledge and expertise through numerous publications, lectures, and collaborations, inspiring the next generation of pathologists and clinicians. His work continues to shape the future of healthcare internationally.